FDA Clearance Tracker · P990009-S002
FLOSEAL MATRIX HEMOSTATIC SEALANT
Last checked: Nov 20, 2026Latest source record: Dec 12, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Dec 12, 2000
Approved
Time to decision
49 days
Received Oct 24, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990009-S002
- Device name
- FLOSEAL MATRIX HEMOSTATIC SEALANT
- Applicant
- Baxter Healthcare Corp
- Applicant location
- Round Lake, IL
- Received
- Oct 24, 2000
- Decided
- Dec 12, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990009
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A LABELING CHANGE.
Source documents
Other decisions for Baxter Healthcare Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Helion Viewer Suite510(k)
K254265 · Decided May 27, 2026 · 148 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.